US Stock MarketDetailed Quotes
ADMA ADMA Biologics
- 15.960
- +3.770+30.93%
Close Aug 9 16:00 ET
- 15.950
- -0.010-0.06%
Post 20:01 ET
3.72BMarket Cap114.00P/E (TTM)
16.640High14.950Low14.57MVolume15.100Open12.190Pre Close230.29MTurnover6.40%Turnover RatioLossP/E (Static)233.08MShares16.64052wk High19.75P/B3.63BFloat Cap3.06052wk Low--Dividend TTM227.54MShs Float16.640Historical High--Div YieldTTM13.86%Amplitude1.010Historical Low15.808Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
ADMA Biologics Stock Forum
Validating! ADMA was one of my very first picks when I started my journey in stocks. Seeing it take off and succeed based on solid fundamentals is a great boost to my self-confidence in my lebragging.
Hopefully, that doesn't sound too braggy. I'm not anything but a shitty new trader. It's important to recognize success when I have it, though. If for no other reason than to keep morale up during shitty downside weeks.
2Q 2024 Total Revenue of $107.2 Million, a 78% Increase Y-o-Y
2Q 2024 GAAP Net Income of $32.1 Million, a $38.4 Million Increase Y-o-Y
2Q 2024 Adjusted EBITDA(1) of $44.5 Million, a Nearly 600% Increase Y-o-Y
Commercial Scale Production of ADMA’s Innovative Biologics Manufacturing Process Supports a Potential Yield Enhancement of Approximately 20% from Same Start...
The tech sector, specifically semiconductors and Ai/crypto companies, aren't going anywhere. NVDA isn't going to just shrug their shoulders and give up tomorrow.
So long as you have researched and relied on financials, I think it will all come back and probably stronger than ever.
In the meantime, I've added to a couple of "defense" stocks:
$ADMA Biologics (ADMA.US)$ : 58.8% U...
by the end of the year, what price will this stock reach? Any predictions?
NEWS
IMPRESSIVE ER
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
ADMA Biologics reported impressive first quarter 2024 financial results, with a total revenue of $81.9 million, a 44% increase year-over-year. The GAAP net income was $17.8 million, a $24.6 million increase year-over-year. Adjusted EBITDA for Q1 2024 was $26.4 million, a 970% increase year-over-year. The company raised its total revenue guidance for FY 2024 to m...
No comment yet